AI assistant
DEXCOM INC — Director's Dealing 2024
Mar 14, 2024
30198_dirs_2024-03-14_42bffa9e-10b5-4802-acdd-8b142b14a329.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2024-03-12
Reporting Person: Stern Sadie (EVP Chief Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-12 | Common Stock | S | 11633 | $134.4107 | Disposed | 89129 | Direct |
| 2024-03-12 | Common Stock | S | 2437 | $131.4984 | Disposed | 86692 | Direct |
| 2024-03-12 | Common Stock | S | 2577 | $132.4637 | Disposed | 84115 | Direct |
| 2024-03-12 | Common Stock | S | 3297 | $133.43 | Disposed | 80818 | Direct |
| 2024-03-12 | Common Stock | S | 302 | $131.5053 | Disposed | 80516 | Direct |
| 2024-03-12 | Common Stock | S | 75 | $132.7061 | Disposed | 80441 | Direct |
Footnotes
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: Included in this number are 53,995 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,504 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 8,208 of which were granted on November 19, 2020 and shall vest through November 19, 2024.
F3: On December 15, 2022, Ms. Stern adopted a 10b5-1 Plan which was amended on December 12, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F4: This transaction was executed in multiple trades at prices ranging from $130.89 to $131.84. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5: This transaction was executed in multiple trades at prices ranging from $131.98 to $132.86. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F6: This transaction was executed in multiple trades at prices ranging from $133.00 to $133.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F7: This transaction was executed in multiple trades at prices ranging from $131.36 to $131.80. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F8: This transaction was executed in multiple trades at prices ranging from $132.62 to $133.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.